All In MedTech

Device Trial Radar · NCT03247829

Investigation to Optimize Hemodynamic Management of Left Ventricular Assist Devices Using the CardioMEMS™

Investigation to Optimize Hemodynamic Management of HeartMate II™ Left Ventricular Assist Device Patients Using the CardioMEMS™ Pulmonary Artery Pressure Sensor in Advanced Heart Failure

Last checked: Nov 20, 2026Latest source record: Apr 26, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

101

Actual

Start

Aug 24, 2017

Primary completion

Mar 6, 2020

Study completion Jun 30, 2020

Sponsor

Lead sponsor
Abbott Medical DevicesPublic (ABT)
Sponsor type
Industry
First posted
Aug 14, 2017

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This observational post market study is intended to characterize hemodynamic-guided management of patients with an existing left ventricular assist device (LVAD) to protocol specified target ranges and its impact on functional status, quality of life, and readmissions

Conditions

  • Heart Failure

Interventions

  • Hemodynamic management using CardioMEMS HF SystemDevice

    Using the CardioMEMS HF System, clinicians will treat to target PA pressure ranges

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Six Minute Hall Walk (6MHW) DistanceTime frame: Six Months

Locations

23 sites in 1 country. Site status is shown where the registry gives one.

  • Scripps Health

    La Jolla, California

  • USC University Hospital

    Los Angeles, California

  • Ronald Reagan UCLA Medical Center

    Los Angeles, California

20 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.